Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.035 USD | -0.50% | -0.82% | -5.75% |
04-30 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
04-29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- MarketScreener Strategies